NKGNW logo

NKGen Biotech Warrants (NKGNW) CAPEX

Annual CAPEX

$48.00 K
-$115.00 K-70.55%

December 31, 2023

Summary

Performance

1-Year Change

-70.55%

3-Year Change

-89.54%

5-Year Change

-89.54%

15-Year Change

-89.54%

NKGNW CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

8.47%
NKGNW annual capital expenditures is higher than 8.47% of companies in Healthcare sector

High & Low

All-time High

$459.00 K
NKGNW annual capital expenditures is currently -89.54% below its historical high of $459.00 thousand

3-Year Low

$48.00 K
NKGNW annual capital expenditures is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NKGNW previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

N/A
NKGNW next annual earnings announcement has not yet been scheduled

OtherNKGNWcash flowmetrics:

Annual FCF

-$22.00 M
NKGNW annual free cash flow is -$22.00 million

Annual CFO

-$21.95 M
NKGNW annual cash flow from operations is -$21.95 million

Annual CFI

-$48.00 K
NKGNW annual cash flow from investing activities is -$48.00 thousand

Annual CFF

$22.16 M
NKGNW annual cash flow from financing activities is $22.16 million

Quarterly CAPEX

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NKGNW Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$18.00 K
NKGNW quarterly capital expenditures is currently at an all-time high

3-Year Low

$5000.00
NKGNW quarterly capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
NKGNW previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
NKGNW next earnings announcement has not yet been scheduled

OtherNKGNWcash flowmetrics:

Quarterly FCF

-$6.01 M
NKGNW quarterly free cash flow is -$6.01 million

Quarterly CFO

-$6.00 M
NKGNW quarterly cash flow from operations is -$6.00 million

Quarterly CFI

-$15.00 K
NKGNW quarterly cash flow from investing activities is -$15.00 thousand

Quarterly CFF

$6.06 M
NKGNW quarterly cash flow from financing activities is $6.06 million

TTM CAPEX

N/A

June 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

NKGNW TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$35.00 K
NKGNW TTM capital expenditures is currently at an all-time high

3-Year Low

$5000.00
NKGNW TTM capital expenditures is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Jun 30, 2024
NKGNW previous earnings announcement was published on Jun 30, 2024

Next Quarterly Earnings Report Date

N/A
NKGNW next earnings announcement has not yet been scheduled

OtherNKGNWcash flowmetrics:

TTM FCF

-$21.57 M
NKGNW TTM free cash flow is -$21.57 million

TTM CFO

-$21.54 M
NKGNW TTM cash flow from operations is -$21.54 million

TTM CFI

$2000.00
NKGNW TTM cash flow from investing activities is $2000.00

TTM CFF

$20.39 M
NKGNW TTM cash flow from financing activities is $20.39 million

NKGNW CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.5%--
3 y3 years-89.5%--
5 y5 years-89.5%--

NKGNW CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-89.5%at low
5 y5-year-89.5%at low
alltimeall time-89.5%at low

NKGen Biotech Warrants CAPEX History

DateAnnualQuarterlyTTM
Dec 2023
$48.00 K(-70.6%)
$18.00 K(+5.9%)
$35.00 K(+59.1%)
Jun 2023
-
$17.00 K(+240.0%)
$22.00 K(+340.0%)
DateAnnualQuarterlyTTM
Dec 2022
$163.00 K(-64.5%)
$5000.00
$5000.00
Dec 2021
$459.00 K
-
-

FAQ

  • What is NKGen Biotech Warrants annual capital expenditures?
  • What is the all time high annual CAPEX for NKGen Biotech Warrants?
  • What is NKGen Biotech Warrants annual CAPEX year-on-year change?
  • What is the all time high quarterly CAPEX for NKGen Biotech Warrants?
  • What is the all time high TTM CAPEX for NKGen Biotech Warrants?

What is NKGen Biotech Warrants annual capital expenditures?

The current annual CAPEX of NKGNW is $48.00 K

What is the all time high annual CAPEX for NKGen Biotech Warrants?

NKGen Biotech Warrants all-time high annual capital expenditures is $459.00 K

What is NKGen Biotech Warrants annual CAPEX year-on-year change?

Over the past year, NKGNW annual capital expenditures has changed by -$115.00 K (-70.55%)

What is the all time high quarterly CAPEX for NKGen Biotech Warrants?

NKGen Biotech Warrants all-time high quarterly capital expenditures is $18.00 K

What is the all time high TTM CAPEX for NKGen Biotech Warrants?

NKGen Biotech Warrants all-time high TTM capital expenditures is $35.00 K